Can 2 Pills a Day Keep Readmission Away?: Sacubitril/Valsartan to Reduce 30-Day Heart Failure Readmissions.
Publication
, Journal Article
Mentz, RJ; O'Brien, EC
Published in: J Am Coll Cardiol
July 19, 2016
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Am Coll Cardiol
DOI
EISSN
1558-3597
Publication Date
July 19, 2016
Volume
68
Issue
3
Start / End Page
249 / 251
Location
United States
Related Subject Headings
- Valsartan
- Tetrazoles
- Patient Readmission
- Humans
- Heart Failure
- Drug Combinations
- Cardiovascular System & Hematology
- Biphenyl Compounds
- Angiotensin Receptor Antagonists
- Aminobutyrates
Citation
APA
Chicago
ICMJE
MLA
NLM
Mentz, R. J., & O’Brien, E. C. (2016). Can 2 Pills a Day Keep Readmission Away?: Sacubitril/Valsartan to Reduce 30-Day Heart Failure Readmissions. J Am Coll Cardiol, 68(3), 249–251. https://doi.org/10.1016/j.jacc.2016.05.013
Mentz, Robert J., and Emily C. O’Brien. “Can 2 Pills a Day Keep Readmission Away?: Sacubitril/Valsartan to Reduce 30-Day Heart Failure Readmissions.” J Am Coll Cardiol 68, no. 3 (July 19, 2016): 249–51. https://doi.org/10.1016/j.jacc.2016.05.013.
Mentz RJ, O’Brien EC. Can 2 Pills a Day Keep Readmission Away?: Sacubitril/Valsartan to Reduce 30-Day Heart Failure Readmissions. J Am Coll Cardiol. 2016 Jul 19;68(3):249–51.
Mentz, Robert J., and Emily C. O’Brien. “Can 2 Pills a Day Keep Readmission Away?: Sacubitril/Valsartan to Reduce 30-Day Heart Failure Readmissions.” J Am Coll Cardiol, vol. 68, no. 3, July 2016, pp. 249–51. Pubmed, doi:10.1016/j.jacc.2016.05.013.
Mentz RJ, O’Brien EC. Can 2 Pills a Day Keep Readmission Away?: Sacubitril/Valsartan to Reduce 30-Day Heart Failure Readmissions. J Am Coll Cardiol. 2016 Jul 19;68(3):249–251.
Published In
J Am Coll Cardiol
DOI
EISSN
1558-3597
Publication Date
July 19, 2016
Volume
68
Issue
3
Start / End Page
249 / 251
Location
United States
Related Subject Headings
- Valsartan
- Tetrazoles
- Patient Readmission
- Humans
- Heart Failure
- Drug Combinations
- Cardiovascular System & Hematology
- Biphenyl Compounds
- Angiotensin Receptor Antagonists
- Aminobutyrates